Introduction
The prevalence of psychiatric disorders (PD) in persons with epilepsy is high compared to general population. Mood disorders occur in 11 to 62%; psychosis in 7 to 10% and personality disorders in 5 to 33%. [1] [2] [3] [4] [5] [6] Depression is the most frequent PD in persons with epilepsy. [7] [8] [9] It is assumed that the rate of depression ranges from 20 to 55% in patients with refractory epilepsy, especially considering those with temporal lobe epilepsy caused by mesial temporal sclerosis (MTLE). Furthermore, people with epilepsy have a lifetime prevalence of any type of mood disorder higher than that observed in general population or people with other chronic medical disorders. Despite its high prevalence, depression remains underdiagnosed and undertreated in persons with epilepsy, with relevant personal and social costs. 10 Depression has also been described as a common comorbidity in children and adolescents with epilepsy. 1, [11] [12] [13] [14] The presence of depressive symptoms in pediatric population favors the idea of a common pathogenic mechanisms, contradicting the previous concept of depression as a consequence of longer epilepsy duration.
The impact of depression severity in morbidity can be evaluated by some studies of quality of life in patients with refractory epilepsy (9.7 seizures/month; mean duration of epilepsy of 12.7 years). 9, 15 Quality of life (QOLIE-89) summary score was significantly associated with depression scales, but not with the type and or the frequency of seizures, although patients averaged 0.3-51 seizures/month. 15 However, studies in children and adolescents with epilepsy and depression frequently neglect depression severity. It is well-known that different degrees of DS severity may have distinct impacts on school, social, and family functioning, 16 especially in children.
We believe that children and adolescents with TLE may present high rates of moderated and severe depressive symptoms (DS) early in the course of their illness with important impairment on their global functioning. This descriptive cross-sectional study aimed to: (i) determine severity of DS by using a quantitative measure (CDRS-R) and (ii) investigate whether these patients present a global function impairment in these children and adolescents.
Methods

Subjects
Patients enrolled in this study had focal epilepsy and were referred from primary and tertiary centers.
After neurological evaluation, 31 children and adolescents (11.8 AE 2.3 years-old; 56% male) with TLE were invited to participate in the present study.
Inclusion criteria were clinical diagnosis of TLE corroborated by EEG and/or video-EEG and neuroimaging study by 3 Tesla MRI. Epilepsy was classified according to International League Against Epilepsy (ILAE 2001) criteria as symptomatic and probably symptomatic. Patients with symptomatic epilepsy were evaluated and categorized according to their lesion and location (mesial and lateral). Patients with probably symptomatic TLE were determined by ictal video/EEG and concordant interictal EEG findings. Patients with extratemporal epileptiform activity were excluded.
Exclusion criteria were the presence of other chronic medical illness than epilepsy; previous neurosurgery; history of substance and/or alcohol abuse or dependence; pervasive developmental disorder; schizophrenia and severe psychotic disorder.
Patients had neuropsychological evaluation using Block Design and Vocabulary subtests of the Wechsler Intelligence Scale for Children, Third Edition (WISC-III) 20 . The mean estimated
Intelligence Quotient (IQ) was 102.1 (range: 85-135; SD = 14.9).
Patients with moderate to severe mental retardation during determined by the child neurologist during neurological evaluation were excluded. Local ethics committee approved this study and before initial evaluation, we obtained the signed consent from the parent or legal guardians in accordance with the institutional review boards at University of Sao Paulo, Brazil.
Psychiatric evaluation and procedure
The psychiatric evaluation used in this study involved four stages with distinct instruments that will be described as follow: (Kaufman et al., 1996) and diagnosed according to DSM-IV axis-I. Presence of DS was assessed by the Mood Disorders Supplement of KSADS-PL. 
Correlation between patients' demographics and clinical variables with DS severity
Patient-related factors such as age (grouped according to Piaget's cognitive scale: <6 years, 7-13 years, >13 years) and gender were analyzed. Epilepsy variables such as age of onset, duration, seizure control, seizure frequency, refractoriness, antiepileptic drugs (mono-vs polytherapy), seizure type (generalized vs focal), presence of mesial temporal sclerosis and laterality were determined by two epileptologists. These variables were correlated with the severity determined by CDRS-S and CGAS.
Statistical analysis
Statistical analysis was performed by descriptive statistic tests: t-test, Person Chi-Square and Pearson correlation for correlation between DS severity and epilepsy variables. All analyses were performed through Statistical Package for the Social Sciences Version 10 (SPSS).
Results
Twenty-five (80.6%) patients with TLE, 14 boys (56%) with a mean age of 12 years (SD = 2.27) had current DS.
The mean age of epilepsy onset was 5.1 years (SD = 3.7). Children and adolescents with TLE had a mean time of epilepsy duration of 6.5 years (SD = 4.2). Thirteen patients (56%) had refractory epilepsy and three (12%) out of these were submitted to epilepsy surgery. Eleven (44%) patients were in monotherapy. Twelve patients (48%) had well-controlled epilepsy at the time of this evaluation. The criterion for seizure control in these 18 patients was at least 6 months of seizure freedom prior to this assessment. Ten patients (40%) were on monotherapy, 15 (60%) were on polytherapy. Seventeen patients (68%) had symptomatic TLE, 13 (52%) with mesial temporal sclerosis. In the lateral group, two had tumor (DNET), one presented with a focal cortical dysplasia, and one with gliosis. We also included eight patients (32%) with probably symptomatic TLE determined by ictal video/ EEG and concordant interictal EEG findings. Patients with extratemporal epileptiform activity were excluded. The demographics and clinical characteristics of these patients are demonstrated in Table 1 .
Out of these 25 patients, 12 (48%) patients presented with depressive disorder according to DSM-IV criteria (nine with dysthymia and three with major depressive disorder). The mean age of onset of DS was 8.3 years (SD = 2.9) and the mean time of duration of DS was 3.4 years (SD = 2.4) ( Table 2) .
Depressive symptoms were diagnosed in most of these children and adolescents with TLE (76%) at the time of psychiatric assessment for this study. Interval between the emergence of DS and the diagnosis was 3.6 years (SD = 2.3).
Five (20%) patients had the onset of DS concomitant with the first seizure and 18 (72%) after epilepsy onset. Two (8%) patients had the onset of DS before the first seizure, according to parents report. In those patients with DS after the fist seizure, mean interval between the epilepsy onset and the emergence of DS was 4.3 years (SD = 3.7).
Six patients (24%) had other psychiatric comorbidities, three (12%) with ADHD and three (12%) with anxiety disorder.
Severity of DS
CDRS-R T-Score: DS were considered mild in 4 (16%), moderate in 11 (44%) and severe in 10 (40%) patients, according to CDRS-R T-Score (Table 2 ). There was no difference in severity of DS between age (p = 0.377) and gender group comparison (p = 0.132). CGAS Score: Global functioning impairment was considered moderate (CGAS mean = 48.8; SD = 8.9). There were no differences concerning global functioning between gender group (p = 0.699). Adolescents were more impaired than children (p = 0.038).
Clinical variables and DS severity
There were no correlation between severity of DS and seizure control (p = 0.936), age of onset (p = 0.731) and duration of epilepsy (p = 0.602). There was no difference between severity of DS when comparing those with and without hippocampal atrophy (p = 0.614) or laterality. Impairment of global functioning was not associated with epilepsy variables (p > 0.05) ( Table 3 ).
Discussion
Depression is the most common PD in people with epilepsy. Although the prevalence of DS was high compared to previous studies with a heterogeneous group of children with epilepsy, it was similar to studies that included only children with TLE. 20 This finding only corroborates the classical concept that epilepsy is a condition, not one disease, and the study of psychopathology in epilepsy must take this fact into account. Another important finding of this study is the early age of onset of DS, corroborating previous findings.
14 Children and adolescent with DS are at higher risk for recurrence of depressive episodes during their adult years with important psychosocial impact. [21] [22] [23] For children and adolescents with primary depression, early age of onset and the severity of DS associated with non-adherence to treatment or lack of treatment are predictive of recurrence in adult life. 24 It emphasizes the need of a broader approach of epilepsy, encompassing the treatment of PD.
To the best of our knowledge, this study represents the first assessment on the severity of DS and global functioning in children and adolescents with TLE. Our results show that most of children and adolescents with TLE present with DS at moderate to severe level. Therefore, DS affect children and adolescents early in the course of their disease. This finding is a major concern considering that adolescents with epilepsy and depression are frequently underdiagnosed and undertreated. 11, 14, 25, 26 In addition patients with TLE may exhibit significantly greater risk for lowering of intervals of episodes of DS indicating a poorer prognosis for these comorbidities in the context of chronic TLE. 27 Therefore, we are facing a group of high vulnerability to develop recurrence of severe DS increasing morbidity, co-morbidity with other psychiatric disorders such as substance abuse and mortality by along their lives. 24, 28 There were no differences in DS severity between age and gender groups. In general, the experience of depression is highly similar for children and adolescent and for girls and boys with some developmental differences in the phenomenology of DS with the increase of the age 29 though the prevalence of depressive disorder is high in female group in adolescents. The study of Modli et al. 30 showed that children diagnosed with a single seizure or epilepsy have similar clinically significant impairments in quality of life. Questionnaires of quality of life, although important measures, are subjective measures of how affected is the patients by its chronic disorder, which not take into account the misperception of the patient about his own condition in terms of its limitations for daily activities. For this study, we used an objective measure of global functioning impairment -the CGAS Score. Global function scale represent an objective measure of a disease in daily activities, such as school, family, playing with peers, etc. The lack of correlation between clinical variables and CGAS Score for global functioning impairment corroborates previous findings with quality of life questionnaires in patients with epilepsy that showed that depression was more important than seizure frequency. 31, 32 Children and adolescents with TLE showed a moderate global functioning impairment. However, adolescents with DS associated to TLE scored higher in global functioning than children. It is around adolescence when individuals have more social and academic activities and are more responsible for daily tasks, in way adolescents may be more impaired when depressed compared to children. In adolescence, children achieve the ability to think abstractly 33 leading to a better understanding about the disease and the impact on life functioning. The sense of lack of control associate with seizures unpredictability combined with negative attitudes toward the seizures 13 aggravated by cognitive distortion associated to depression may also lead this youth to be more global impaired when depressed. In addition, it must be postulated that the impact of TLE on cognitive functioning, such as memory and executive function, 34, 35 reduce both the academic achievements and the daily life efficiency in adolescents and adults 36 which may lead to DS aggravation. Epilepsy variables were not correlated to the severity of DS. Studies in adults have reported that DS is more frequent in patients with MTLE-HS, independent of the lateralization. 37, 38 Contradicting these findings, in this study there were no differences in the severity of DS and global functional impairment between lateral and mesial temporal lobe epilepsy and between symptomatic and probably symptomatic group. The existing hypothesis for this age effect is that chronic excessive neuronal excitatory observed in MTLE-HS patients may be associated to a worsening DS and lowering the intervals between depressive episode 27 and the severity of DS along the course of MTLE-HS illness. We hypothesized that in this pediatric series, we are probably evaluating the first manifestation of DS in children with shorter epilepsy duration, which may be not diagnosed in most of these patients until they reach adult life and this fact may be one of the reasons. Association between hippocampal atrophy and severity of DS is still controversial in studies with adults. [39] [40] [41] Our results may be affected by the small sample size in each group. A further study with larger number of patients is indeed necessary to establish this association in pediatric population. In this study, patients with IQ lower than 80 were excluded. Therefore, we must consider the level of intelligence quotient (IQ) of our patients, since higher IQ may relate to a higher awareness of difficulties determining depressive symptoms but also to stronger strategies to handle with the sickness, such as an active participation and compliance to pharmacological assumption, reducing the specific impact of medical variables related to epilepsy, such as seizure severity.
The main limitations are the study design and the low sample size. It must be considered that a cross-sectional design, as performed in our work, may be considered inappropriate to investigate DS associated to epilepsy. Depressive symptoms in persons with epilepsy present an intermittent course. 42 Therefore, the severity of DS at one specific moment may not represent the real severity level of DS in children and adolescents with TLE when evaluated with a longitudinal study. Another point to be considered is the absence of a specific systematizing instrument to evaluate DS in interictal period which led us to use instruments used for DS in general population. Although this was not a community-based study, the bias generated by studies in a in a tertiary epilepsy center were partially ruled-out since patients from primary care centers were included. The small sample size implies that the impact of comorbidities such as ADHD and anxiety cannot be evaluated. By the same token, some aspects of epilepsy such as the use of Topiramate that may have a negative impact on DS could not be evaluated in the present study. These associations remain to be determined in a further study with a larger sample size.
Clinical implications
Our findings suggest that children and adolescents with TLE have moderate to severe DS early in the course of their illness with a relevant impact in their global functional activities, which are frequently neglected by those in care of these patients. This early presentation if not diagnosed and treated may put these children and adolescents with TLE at risk of recurrent depressive episodes, mortality by and archived poor social, family, work, academic and affective relationship functioning along their lives. Although there were no correlation between epilepsy clinical variables and severity of depressive symptoms and global functioning, more systematic studies are necessary to determine the clinical features and course of depressive disorders in children and adolescents with TLE.
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